Buonafine 2020.
Study characteristics | |||
Patient Sampling |
Purpose: diagnosis of SARS‐CoV‐2 infection (mild COVID‐19 disease); to investigate the prevalence and clinical characteristics of HCWs with COVID‐19 symptoms Design: cross‐sectional cohort study, prospective data collection Recruitment: HCW from the Santa Casa de São Paulo Hospital were defined as symptomatic and invited to participate in the study if presented with self‐reported fever or symptoms suspicious of COVID‐19 Sample size: n = 295 (125 cases) Inclusion criteria: HCW with self‐reported fever or any of the following: acute respiratory symptoms (cough, nasal congestion, sore throat, shortness of breath), loss or changed sense of smell or taste, ocular symptoms, headache, arthralgia, myalgia, fatigue, diarrhoea, nausea, and vomiting Exclusion criteria: none specified |
||
Patient characteristics and setting |
Facility cases: RT‐PCR‐positive for SARS‐CoV‐2 Facility controls: RT‐PCR‐negative for SARS‐CoV‐2 Country: Brazil Dates: 21 March 2020‐22 May 2020 Symptoms and severity: mild to moderate to severe: 7% hospitalised 2% died, 91% of included individuals had headache, 88% nasal congestion, 85% cough, 85% fatigue, 81% myalgia Demographics: mean age cases 35 years, controls 34 years M%/F%: cases 40.0/60.0, controls 23.6/76.4 Exposure history: all HCW. Close contact with confirmed COVID‐19: cases 73%; controls 74% |
||
Index tests |
|
||
Target condition and reference standard(s) |
|
||
Flow and timing | Timing not specified | ||
Comparative | |||
Notes | Funding: none declared | ||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Unclear | ||
Was a case‐control design avoided? | Yes | ||
Did the study avoid inappropriate exclusions? | No | ||
Did the study avoid inappropriate inclusions? | Yes | ||
Could the selection of patients have introduced bias? | High risk | ||
Are there concerns that the included patients and setting do not match the review question? | Low concern | ||
DOMAIN 2: Index Test (All tests) | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Yes | ||
If a threshold was used, was it pre‐specified? | No | ||
Could the conduct or interpretation of the index test have introduced bias? | High risk | ||
Are there concerns that the index test, its conduct, or interpretation differ from the review question? | Low concern | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Unclear | ||
Could the reference standard, its conduct, or its interpretation have introduced bias? | Low risk | ||
Are there concerns that the target condition as defined by the reference standard does not match the question? | Low concern | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Unclear | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Yes | ||
Could the patient flow have introduced bias? | Unclear risk |